Welcome to the
Translational Research In Oncology Website
TRIO is dedicated to advancing translational cancer research by bringing forward innovative and targeted therapeutic concepts into the clinical trial setting.
TRIO is the association of a global investigator network with the following operational divisions:
- Translating preclinical findings into clinical research.
- Validating molecular markers and characterizing mechanisms of action.
- Generating clinical hypotheses based on the underlying biology of the disease.
- Assessing in vitro new agents in combination with others.
- Partnering with industry in the development of novel anticancer agents.
- Conducting innovative clinical research across all phases of drug development and disease sites.
- Working with investigators who deliver high quality data and guarantee patient safety.
- Maintaining focus on the ultimate goal - that improving quality of life and survival in patients with cancer.
